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We thank our esteemed clinical colleagues Bagić et al. (2018) for their interest in our paper "IFCN-
endorsed practical guidelines for clinical magnetoencephalography (MEG)" (Hari et al. 2018). We hereby 
respectfully respond to the criticism that our paper has (1) a confusing title and (2) poorly-weighted contents.  
Bagić et al. (2018) feel that our title is easily confused with "legitimate Clinical Practice Guidelines 
(CPGs)". We specifically did not use the term clinical practice in our title. Furthermore, reading the brief 
abstract should readily rectify any lingering confusion in the mind of a potential reader. 
Bagić et al. (2018) also consider that the content of our paper is "inadequate for guidelines in clinical 
MEG, as practiced". They state—as did we—that MEG currently has only two well-established clinical 
applications: diagnostics of epilepsy, including identification of epileptic foci, and preoperative evaluation. 
They argue that we should have described these two existing applications in much more detail, including 
instructions how to carry out and evaluate recordings in patients suffering from different types of epilepsy, 
with specific considerations for different age groups. This information certainly is an indispensable part of 
the eventual CPGs for MEG. Here we explicitly did not want to dictate how expert clinicians employing 
MEG should make their exams as they, despite standardization, should be allowed to have freedom in 
carrying out technically sound MEG recordings, analyses, and interpretation. 
Importantly, none of the five anonymous reviewers of our paper expressed a concern of lacking 
emphasis on the established clinical applications. Instead, they demanded us to expand the discussion about 
the potential clinical applications that may emerge as an outcome of the ongoing MEG research, eventually 
diversifying the clinical use of MEG. 
Naturally, our paper is not the only source of information for clinical MEG applications. Our reference 
list of 350 items includes several review and guideline papers that we recommended for further reading.  
A different group of authors would, of course, write a different paper. Our motivation to emphasize 
the basic principles is that over the years we have seen too many technically poor MEG recordings and 
analyses that do not increase the understanding of healthy and diseased brains. Such recordings can be 
useless, or even misleading, in clinical practice.  
It is also our experience that junior clinicians, e.g., neurologists, entering the MEG field typically 
know much more about the different clinical disorders, including semiology of epilepsy, than they know 
about the basic principles of MEG and EEG. Such basic information is, however, quintessential for proper 
interpretation of the MEG results and even for the selection of the right problems and patients to be studied 
with MEG. Only on the basis of a solid foundation, expert clinicians can carry out sophisticated exams and 
will arrive at the correct conclusions for the benefit of the patients. 
We are pleased that our paper has triggered a strong intent for the community to write internationally 
agreed CPGs for MEG studies. However, excluding from such an effort people on the basis of their 
backgrounds (e.g. physics or basic neuroscience), irrespective of their skills, would be shortsighted and a 
clear step backwards in a field that continues to flourish by virtue of strong interdisciplinary collaboration. 
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